Lands' End's stock rallies as retailer posts stronger-than-expected sales
By Steve Gelsi
Company's share price breaks through $10 for the first time since August 2023
An earlier version of this story misspelled Lands' End's corporate name.
Lands' End Inc.'s stock rose 14% - reaching its highest level in about seven months on Wednesday - after its fourth-quarter sales beat analyst estimates.
Lands' End's fourth-quarter revenue dipped by 2.8% to $514.85 million, from $529.6 million in the year-ago quarter, but the company was well above the $502.2 million FactSet consensus sales estimate.
The company grew its gross margin by 5.5% and reduced its inventory by 29% in the fourth quarter. It also announced a fresh $25 million stock-buyback plan.
Lands' End's (LE) stock was rallying by $1.35 a share to $10.65 a share in midday trades. It's the first time the stock cracked the $10 level since August 2023.
Chief Executive Andrew McLean said Lands' End focused on new products and fewer markdowns, while having a "significantly enhanced" inventory position during the year.
The Dodgeville, Wisc.-based retailer said its fourth-quarter loss widened to $8.62 million, or 27 cents a share, from a loss of $3.3 million, or 10 cents a share, in the year-ago quarter.
The company's adjusted profit of 25 cents a share fell short of the estimate of 27 cents a share by two analysts surveyed by FactSet.
Looking ahead, Lands' End expects to generate a 2024 profit of 3 cents a share to 32 cents a share, compared to the analyst estimate of 11 cents a share.
Including Wednesday's gains, Lands' End stock is up 10.8% in 2024, compared to a 9.4% rise by the S&P 500 SPX.
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
03-27-24 1351ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth